01 Sep Ozempic vs. Wegovy vs. Mounjaro vs. Zepbound: What’s Actually Different?
Medically reviewed by Elyssa Blissenbach, MD · Board Certified, American Boards of Internal Medicine & Obesity Medicine
Licensed to practice in FL, GA, SC, AL, VA, NC · NPI #1881601714 · Last reviewed: 2026-09-01
Key Takeaways
- There are only two drugs behind the four names: semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound).
- The pairs differ by FDA indication: Ozempic and Mounjaro are approved for type 2 diabetes; Wegovy and Zepbound for chronic weight management.
- Trial averages: ~15% body weight lost on semaglutide (STEP-1) vs. ~21% on tirzepatide (SURMOUNT-1).
- Which one you should take depends on your health history and coverage — not the brand name.
The four biggest names in prescription weight loss — Ozempic, Wegovy, Mounjaro, and Zepbound — are really just two medications sold under four brands. Ozempic and Wegovy are both semaglutide; Mounjaro and Zepbound are both tirzepatide. What separates the pairs is the FDA indication on the label (diabetes vs. weight management), the maximum dose, and how insurance treats them.
Here’s the full breakdown, so the brand names stop being confusing.
How Do the Four Medications Compare?
| Brand | Active Ingredient | FDA-Approved For | Max Maintenance Dose | Dosing |
|---|---|---|---|---|
| Ozempic | Semaglutide | Type 2 diabetes | 2 mg | Weekly injection |
| Wegovy | Semaglutide | Chronic weight management | 2.4 mg | Weekly injection |
| Mounjaro | Tirzepatide | Type 2 diabetes | 15 mg | Weekly injection |
| Zepbound | Tirzepatide | Chronic weight management | 15 mg | Weekly injection |
(A fifth product, Rybelsus, is oral semaglutide approved for type 2 diabetes — the only non-injection in the family.)
What’s the Difference Between Semaglutide and Tirzepatide?
Semaglutide activates one gut-hormone receptor (GLP-1); tirzepatide activates two (GLP-1 and GIP). Both slow stomach emptying and tell your brain you’re full, so you eat less without white-knuckle willpower. The dual action is the leading explanation for tirzepatide’s stronger trial numbers — roughly 21% average body-weight loss in SURMOUNT-1 versus roughly 15% for semaglutide in STEP-1. For the deeper clinical comparison, see our semaglutide vs. tirzepatide guide.
Why Does the FDA Indication Matter So Much?
Because it drives coverage and access, not effectiveness. The same molecule behaves the same way in your body regardless of the label — but your insurer cares deeply about it: plans that cover Ozempic for diabetes routinely refuse Wegovy for weight loss, and vice versa. That’s why the practical medication choice is usually made with your coverage in view — our Florida insurance coverage guide covers that maze in detail, and cash-pay programs sidestep it entirely at published program rates.
Which One Should You Choose?
Treat it as two decisions, in order:
- Decision 1 — molecule: semaglutide has the longer track record and a gentler single-target profile some GI-sensitive patients prefer; tirzepatide has the stronger average results and suits larger weight loss goals or insulin resistance. Your provider weighs your history here.
- Decision 2 — brand/route: driven almost entirely by what your insurance covers and whether you’re using a cash-pay program. This is logistics, not medicine.
Both medication families are available at Get Skinny Jax — semaglutide programs and tirzepatide programs — and whether you’re a good candidate gets settled at a free consultation, where the choice is made on your medical fit rather than inventory.
Frequently Asked Questions
Is Ozempic the same as Wegovy?
They contain the same active ingredient — semaglutide — but they are different products. Ozempic is FDA-approved for type 2 diabetes and dosed up to 2 mg weekly; Wegovy is FDA-approved for chronic weight management and dosed up to 2.4 mg weekly. Insurance treats them completely differently because of those indications.
Is Mounjaro the same as Zepbound?
Same relationship: both contain tirzepatide. Mounjaro carries the type 2 diabetes indication; Zepbound carries the chronic weight management indication.
Can I take Ozempic or Mounjaro for weight loss without diabetes?
Providers can and do prescribe them off-label for weight management — off-label prescribing is legal and common. The trade-off is insurance: plans rarely cover the diabetes-branded products without a diabetes diagnosis, which is where cash-pay programs come in.
Which medication produces the most weight loss?
In trial averages, tirzepatide leads: about 21% of body weight in SURMOUNT-1 (72 weeks) versus about 15% for semaglutide in STEP-1 (68 weeks). Head-to-head data points the same direction. But individual response varies widely, and plenty of patients hit their goals on semaglutide.
How do I know which one is right for me?
It comes down to your medical history, weight loss goal, side-effect tolerance, and what your insurance will cover — which is exactly what a consultation sorts out. At Get Skinny Jax the consultation is free, and both medication families are available.
This article is informational and not a substitute for medical advice. Talk to a licensed provider before starting any prescription medication.